This invention relates to novel polymorphic/pseudopolymorphic forms of
arginine salt of
3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid, having
the formula I shown below. The invention also relates to a pharmaceutical
composition comprising the novel polymorphic form or their mixture and a
pharmaceutically acceptable carrier. The polymorphic forms of the present
invention are more active, as antidiabetic and hypolipidemic agent, than
the novel 3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid.
##STR1##